insights_auto
Outlook: 67.7% bullish·2.9% bearish
Go to analysischevron_right
CSL:ASX
CSL Ltd
A$182.30
arrow_upward
+0.21%(+0.39) 1D
Sep 29, 4:14:36 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$182.00
High
A$183.65
Low
A$181.66
Mkt. cap
87.48B
Avg. vol.
1.51M
Volume
779.21K
Dividend
1.56%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 11, 2023
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.63
Shares outstanding
479.88M
No. of employees
29K
Open
A$182.00
High
A$183.65
Low
A$181.66
Mkt. cap
87.48B
Avg. vol.
1.51M
Volume
779.21K
Dividend
1.56%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 11, 2023
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.63
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
The Motley Fool Australia
·
5 hours ago
Buy, hold, sell: Fortescue, Westpac, CSL shares
Kalkine Media
·
9 hours ago
Could CSL (ASX:CSL) Extend Its Share Price Recovery?
Yahoo Finance Australia
·
19 hours ago
SSUMY or CSL: Which Is the Better Value Stock Right Now?
Kalkine
·
5 days ago
CSL Limited Buys Back 41,958 Shares on 23 September in On-Market Program
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com